Diabetes
The latest information on glucose, hypoglycemia, hyperglycemia, insulin, metformin, and more, drawn from across our primary care and specialty care areas. Sign up now for monthly e-mail alerts on new content.
SUMMARY AND COMMENT
Comparison of Three Insulin RegimensFree
- November 5, 2009
- Allan S. Brett, MD
- General Medicine
Adding once-daily basal insulin to oral therapy conferred some advantages over alternate regimens.
- Reviewing:
- Holman RR et al. N Engl J Med 2009 Oct 29; 361:1736
SUMMARY AND COMMENT
Glucose Control in Type 2 Diabetes: Review of Cardiovascular Outcomes
- November 5, 2009
- Richard Saitz, MD, MPH, FACP, FASAM
- General Medicine
Intensive control led to fewer nonfatal MIs but no change in 5-year all-cause mortality.
- Reviewing:
- Kelly TN et al. Ann Intern Med 2009 Sep 15; 151:394
SUMMARY AND COMMENT
We Need to Put Vitamin D Back in Children and AdolescentsFree
- November 4, 2009
- Alain Joffe, MD, MPH, FAAP
- Pediatrics and Adolescent Medicine
Many U.S. children and adolescents have low vitamin D levels, and such levels are associated with adverse physiologic processes.
- Reviewing:
- Kumar J et al. Pediatrics 2009 Sep; 124:e362
SUMMARY AND COMMENT
Darbepoetin 
in Patients with Type 2 Diabetes, Chronic Kidney Disease, and Anemia
- November 3, 2009
- Paul S. Mueller, MD, MPH, FACP
- General Medicine
The drug provides little benefit and might cause harm.
- Reviewing:
- Pfeffer MA et al. N Engl J Med 2009 Oct 30
SUMMARY AND COMMENT
Gabapentin–Nortriptyline Combination Therapy for Neuropathic Pain
- October 27, 2009
- Bruce Soloway, MD
- General Medicine
Pain intensity was lower with combination therapy than with either monotherapy.
- Reviewing:
- Gilron I et al. Lancet 2009 Oct 10; 374:1252
SUMMARY AND COMMENT
Effect of Weight Loss on Obstructive Sleep Apnea in People with Type 2 Diabetes
- October 22, 2009
- Jamaluddin Moloo, MD, MPH
- General Medicine
Losing 25 lbs resulted in significantly fewer OSA events in obese patients.
- Reviewing:
- Foster GD et al. Arch Intern Med 2009 Sep 28; 169:1619
SUMMARY AND COMMENT
Resistant Hypertension: Is There a Role for a New Drug?
- October 7, 2009
- Joel M. Gore, MD
- Cardiology
An endothelin antagonist performed well in a randomized trial, but much research remains to be done.
- Reviewing:
- Weber MA et al. Lancet 2009 Sep 14
SUMMARY AND COMMENT
Walking Program for Patients with Impaired Glucose Tolerance
- October 1, 2009
- Thomas L. Schwenk, MD
- General Medicine
Pedometer use resulted in more walking and lower glucose levels.
- Reviewing:
- Yates T et al. Diabetes Care 2009 Aug; 32:1404
SUMMARY AND COMMENT
Does Treatment for Mild Gestational Diabetes Improve Pregnancy Outcomes?Free
- September 30, 2009
- Ann J. Davis, MD
- Women's Health
Treatment lowered risk for maternal hypertensive disorders and complications related to excessive fetal growth, but not for perinatal mortality and severe neonatal complications.
- Reviewing:
- Landon MB et al. N Engl J Med 2009 Oct 1; 361:1339
SUMMARY AND COMMENT
Angiotensin-Receptor Blockers for MicroalbuminuriaFree
- September 24, 2009
- Richard Saitz, MD, MPH, FACP, FASAM
- General Medicine
ARBs didn't prevent adverse renal outcomes in patients with cardiovascular disease or diabetes.
- Reviewing:
- Mann JFE et al. Ann Intern Med 2009 Jul 7; 151:1
